Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Product is recalled because it was made with water contaminated with chemicals perfluorooctanoic acid (PFOA) and perluorooctanesulfonic acid (PFOS). The observed PFOS and PFOA levels exceed…
Product is recalled because it was made with water contaminated with chemicals perfluorooctanoic acid (PFOA) and perluorooctanesulfonic acid (PFOS). The observed PFOS and PFOA levels exceed…
Product may contain undeclared milk.
Product is recalled because it was made with water contaminated with chemicals perfluorooctanoic acid (PFOA) and perluorooctanesulfonic acid (PFOS). The observed PFOS and PFOA levels exceed…
Product is recalled because it was made with water contaminated with chemicals perfluorooctanoic acid (PFOA) and perluorooctanesulfonic acid (PFOS). The observed PFOS and PFOA levels exceed…
Product is recalled because it was made with water contaminated with chemicals perfluorooctanoic acid (PFOA) and perluorooctanesulfonic acid (PFOS). The observed PFOS and PFOA levels exceed…
Lyrical Foods is voluntarily recalling four flavors of Kite Hill Almond Yogurt with best by dates 07/03/17 and 07/04/17 as some of these packages have spoiled before the best by date.
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the…
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Lack of Assurance of Sterility
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Failed Dissolution Specifications: Drug release test result, obtained during routine 9-month stability testing, which was below specification for one tablet. Teva cannot at this time…
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Lack of Assurance of Sterility: Customer complaints for leaking bags.
Browse recent months with enough recall history for useful comparison.
